COMP <GO>
RXO vs MA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
RXO Inc. (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: RXO 3
— MA 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MA
LAST: $27.49 (-0.58%) • MKT CAP: $4.56B
options-implied-move
7.20%
LAST: $638.01 (+0.36%) • MKT CAP: $556.88B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RXO VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RXO | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.90% | 33.50% | -36.40 | MA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 29.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.18% | 3.08% | -3.26 | MA | /fcf-yield <GO> |
| Operating Margin | -1.40% | 57.60% | -59.00 | MA | /operating-margins <GO> |
| Net Profit Margin | -1.70% | 45.60% | -47.30 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | 16.40% | +9.80 | RXO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | MA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.35 | 11.17 | -7.82 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.20% | 6.60% | +0.60 | MA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 70.6 | -14.00 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.90 | +0.19 | RXO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 31.2x | -9.20 | RXO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.56B | $556.88B | -$552.32B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RXO REV | MA REV | RXO GROSS % | MA GROSS % | RXO FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.74B | $32.79B | 44.0% | 44.0% | -$8.0M | $17.16B |
| FY 2024 | $4.55B | $28.17B | 44.0% | 44.0% | -$57.0M | $14.31B |
| FY 2023 | $3.93B | $25.10B | 44.0% | 44.0% | -$87.7M | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RXO // BETA 1.09
MA // BETA 0.90